DOC Medical Center to Launch Pioneering Neurosciences Division as part of Qatar National Day celebrations
DOC Medical Center, one of Qatar’s leading institutions in specialised orthopaedics and neurological care, has announced the launch of its new DOC Neurosciences Division, marking a major milestone in the country’s evolving healthcare landscape. As part of the Qatar National Day celebrations, the new division reflects a national commitment to advancing world-class neurological and spinal care in the State of Qatar. The launch of DOC Neurosciences introduces a comprehensive, future-ready model for the diagnosis, treatment, and rehabilitation of complex brain, spine, and neurological disorders. The division brings together internationally recognised clinical expertise, cutting-edge surgical technologies, and patient-centric innovations under one integrated platform. Advancing Neurological and Spine Care in Qatar Designed to address the growing regional demand for sophisticated, minimally invasive neurological and spinal treatments, DOC Neurosciences is built on three core pillars: world-class surgical expertise, advanced medical technology, and holistic neuro-rehabilitation. The division represents a strategic investment in specialised care that aligns with Qatar National Vision 2030’s focus on healthcare excellence, innovation, and sustainable development. Mr. Khalid Ahmad A A Alshaibi, Chief Guest of Honour, commented:“Launching DOC Neurosciences on Qatar National Day is a powerful reflection of the nation’s spirit of progress. This initiative significantly strengthens Qatar’s healthcare capabilities and demonstrates a commitment to providing world-class, compassionate neurological care to the community.” Leadership Driving Clinical Excellence Dr. Emmanuel Tolessa, Founder and Chairman of DOC Medical Center, stated:“This is more than an expansion; it is the realisation of a long-standing vision to centralise exceptional neuro-spine care. By bringing together some of the world’s leading specialists and technologies under one roof, DOC Neurosciences will redefine the standard of care for patients in Qatar and the wider region.” Leading the division is Dr Sirajeddin Belkhair, Director of DOC Neurosciences and Senior Consultant Neurosurgeon, who emphasised the role of precision and innovation in modern neurosurgery. He highlighted the use of advanced neuronavigation systems such as Brainlab (Germany) to enhance surgical accuracy, patient safety, and clinical outcomes, particularly in complex brain tumour and neurological procedures. Complementing this approach, Dr. Ashraf Megahed, Medical Director and Senior Consultant Neurosurgeon, brings a specialised focus on minimally invasive and endoscopic spine surgery, offering advanced solutions for conditions such as herniated discs, spinal stenosis, and degenerative spine disorders—often enabling faster recovery and outpatient-level care. Revolutionising Patient Experience Through Augmented Reality In a first for Qatar’s private healthcare sector, DOC Neurosciences will introduce an Augmented Reality (AR) platform to transform patient education and engagement. Through immersive 3D visualisation of patient-specific anatomy, clinicians can clearly explain diagnoses and treatment plans, empowering patients and families to actively participate in their care journey. Integrated Neuro-Rehabilitation for Complete Recovery True to DOC Medical Center’s holistic philosophy, the Neurosciences Division is fully integrated with a specialised Neuro-Rehabilitation Department, ensuring seamless continuity of care from surgery through recovery. The multidisciplinary rehabilitation team focuses on restoring mobility, independence, and quality of life—completing the full spectrum of neuroscientific care. With the launch of DOC Neurosciences, DOC Medical Center reinforces Qatar’s position as a rising regional hub for advanced neurological care, spinal surgery, and medical innovation, setting a new benchmark for excellence in patient-focused healthcare.
DOC Medical Center – Izghawa Branch Launches Qatar’s Flagship MBST Regenerative Therapy Center in Joint Venture with Nabina Group
DOC Medical Center has officially launched its new Izghawa Branch, establishing Qatar’s first flagship hub dedicated to MBST® (Molecular Biophysical Stimulation) regenerative therapy through a landmark Joint Venture with Nabina Group’s Healthcare Division. The center positions Qatar at the forefront of non-invasive regenerative medicine in the GCC, reinforcing the nation’s growing influence as a regional healthcare innovation leader. The new facility will serve as the country’s premier destination for this groundbreaking German MBST technology, offering evidence-based therapy for chronic pain, arthritis, osteoporosis, sports injuries, spine conditions, and degenerative musculoskeletal diseases. As the MBST Master Licensee for the entire GCC, Nabina Group’s partnership with DOC Medical Center creates a transformative model of collaboration aimed at expanding the therapy across the GCC and Africa. This launch aligns with Qatar National Vision 2030, advancing national goals in health innovation, wellness, active ageing, and knowledge-based economic development. A Strategic Joint Venture Driving GCC-Wide Medical Innovation Mr Mansoor Nabina, CEO of MBST Qatar and Healthcare Division Lead at Nabina Group, highlighted the regional significance of the partnership: “As the MBST Master Licensee for the GCC, our Joint Venture with DOC Medical Center establishes the Izghawa Branch as the cornerstone of our regional expansion strategy. This is more than opening a clinic — it is the activation of a regional gateway for MBST regenerative technology. Our vision spans across the GCC and into Africa, and DOC Medical Center – Izghawa will serve as the model for clinical excellence, patient outcomes, and therapeutic innovation. We are proud to bring world-class, non-invasive regenerative solutions to Qatar and beyond.” Through this partnership, the center will offer exclusive MBST treatment protocols, supported by advanced diagnostics and patient-monitoring systems designed to deliver superior regenerative outcomes without surgery or medication dependency. Leadership Insight: Transforming Qatar’s Healthcare Landscape Dr Emmanuel Tolessa, Founder and Chairman of DOC Medical Center Qatar, emphasised the national health impact: “The introduction of MBST technology through DOC Medical Center – Izghawa is a milestone in advancing Qatar’s healthcare standards. By partnering with Nabina Group, we ensure access to the most advanced regenerative medicine protocols. This innovation has the potential to significantly reduce invasive procedures and long-term medication use while improving the quality of life for patients living with chronic musculoskeletal conditions. With Qatar’s ageing population and increasing prevalence of joint and spine disorders, the new center will play a vital role in addressing national health priorities and supporting long-term wellbeing.” The Izghawa Branch will serve as the primary clinical and training hub for MBST therapy, enabling healthcare professionals across the region to access specialised certification, research insights, and application techniques. A New Era of Regenerative Medicine in Qatar The launch of the DOC Medical Center – Izghawa Branch marks a bold step forward in Qatar’s commitment to integrating cutting-edge medical technology, non-invasive regenerative therapy, and patient-centered healthcare innovation. With MBST now accessible through this flagship center, Qatar stands poised to become the GCC’s leader in regenerative medicine, musculoskeletal health, and advanced therapeutic solutions, offering life-changing treatments for residents, athletes, seniors, and individuals seeking long-term recovery without surgery.
HH Sheikha Moza bint Nasser Attends Opening of Precision Medicine and the Future of Genomics Summit 2025
Qatar Foundation and Sidra Medicine highlight 11 years of groundbreaking progress in Precision Health and Genomics. Her Highness Sheikha Moza bint Nasser, Chairperson of Qatar Foundation (QF), attended the opening of the Precision Medicine and the Future of Genomics (PMFG) Summit 2025, held at the Qatar National Convention Centre (QNCC). The prestigious event marks more than a decade of Qatar’s leadership and investment in precision medicine, genomics, and health innovation. The ceremony was also attended by HE Mansoor bin Ebrahim bin Saad Al Mahmoud, Minister of Public Health, alongside senior government officials, diplomats, and global healthcare and academic leaders — underscoring Qatar’s commitment to advancing the future of healthcare. A Decade of Milestones in Precision Medicine The PMFG Summit 2025 opened with keynote addresses from Julia Vitarello, Founder & CEO of Mila’s Miracle Foundation, and Prof. Ed Liu from The Jackson Laboratory. The ceremony concluded with the flagship panel discussion:“From Personalised to Population-Scale: Building a Thriving Precision Medicine Sector in Qatar.” In his remarks, Prof. Khalid Fakhro, Chief Research Officer at Sidra Medicine, stated: “As we celebrate 11 years of PMFG, we reaffirm our commitment to advancing genomic science, translational research, and precision health implementation. We extend our appreciation to all speakers, partners, sponsors, and the growing scientific community in Qatar who make this summit truly exceptional.” Driving the Future of Genomics and Healthcare Innovation Co-organised by Sidra Medicine and the Qatar Precision Health Institute, and held under the patronage of Qatar Foundation, the PMFG Summit focuses on three major transformative pillars shaping the next era of global healthcare: The summit brings together global experts to explore how genomics, technology, and clinical strategy can be integrated into population-wide healthcare transformation — positioning Qatar as a frontrunner in precision medicine. What’s Ahead on Day 2 – December 3 The second day of PMFG 2025 will feature: As Qatar continues shaping a world-class ecosystem for precision health, the PMFG Summit stands as a cornerstone of its national vision to lead scientific discovery, improve patient outcomes, and build a sustainable healthcare future.
MENA Fintech & Insurtech Festival 2025: Qatar Takes Center Stage in Regional Financial Innovation
The MENA Fintech & Insurtech Festival 2025 officially opened at the Doha Exhibition & Convention Centre (DECC), igniting two days of high-impact dialogue, innovation showcases, and strategic collaboration opportunities that are redefining the financial technology and insurance technology landscape across the region. Bringing together global fintech innovators, insurtech leaders, investors, regulators, and policymakers, the festival has quickly established itself as a major platform for advancing the future of finance in Qatar and the wider MENA region. Driving the Future of Financial Innovation in Qatar Day One delivered a dynamic program of keynote speeches, expert-led panels, and immersive workshops. Discussions explored some of the most powerful forces shaping the industry today, including: These conversations highlighted Qatar’s rapidly growing role as a regional hub for digital finance, regtech, blockchain, and AI-driven financial inclusion. What to Expect on Day Two The momentum continues with an exceptional lineup of thought leaders who will dissect the industry’s most transformative topics: Attendees will gain forward-looking insights from industry pioneers shaping the next decade of fintech and insurtech innovation across MENA. A Regional Platform for Growth and Collaboration “As the fintech landscape evolves at an unprecedented pace, our goal is to create a platform that accelerates collaboration, innovation, and regulatory clarity across the MENA region,” said Malik Shishtawi, President of the MENA Fintech & Insurtech Festival. “This festival brings together the brightest minds, the most forward-thinking institutions, and the next generation of startups driving the digital economy.” A Cornerstone Event in the Digital Transformation Landscape Since its inception, the MENA Fintech & Insurtech Festival has become one of the region’s most influential events—championing: The 2025 edition reinforces Qatar’s rising position as a strategic center for fintech leadership, insurtech advancement, and digital transformation.
Health Minister Inaugurates Qatar Medicare 2025 with Participation of 100 Companies
Organised by IFP Qatar in Collaboration with Qatar Chamber H.E. Mr Mansoor bin Ebrahim bin Saad Al Mahmoud, Minister of Public Health, inaugurated the second edition of Qatar’s International Healthcare and Medical Exhibition and Conference – Qatar Medicare 2025, held under the patronage of the Ministry of Public Health (MoPH). The event, organised by IFP Qatar in collaboration with Qatar Chamber, runs from November 11 to 13, 2025, at the Doha Exhibition and Convention Center (DECC), bringing together 100 local and international companies from across the healthcare ecosystem — including 64 local exhibitors and 36 global participants. This year’s edition showcases the latest advancements in healthcare innovation, medical technology, and sustainable health systems, featuring healthcare professionals, hospital representatives, medical service providers, technology experts, and investors from around the world. Public-Private Collaboration in Healthcare Ms Ibtihaj Al Ahmadani, Chair of the Health Committee at Qatar Chamber, reaffirmed the Chamber’s support for achieving self-sufficiency in Qatar’s healthcare and pharmaceutical sectors. “The Qatar Chamber is committed to achieving self-sufficiency in the medical and pharmaceutical sectors. Qatar Medicare reflects the strong public-private collaboration driving Qatar’s healthcare landscape,” Al Ahmadani said. She noted that this year’s event includes the participation of key governmental and semi-governmental entities, such as Hamad Medical Corporation (HMC), as the official partner, and the Ministry of Communications and Information Technology (MCIT), as the government partner. International representation spans 14 countries, featuring leading global organisations including the Africa Centres for Disease Control and Prevention (Africa CDC), UNESCO, World Health Organisation (WHO), and the International Labour Organisation (ILO), alongside numerous regional and private-sector partners. According to Fitch Solutions, Qatar’s healthcare sector is set for rapid expansion, with total health expenditure projected to grow at a CAGR of 14% by 2029, reaching USD 11.5 billion (QAR 41.86 billion) — positioning Qatar as the third-largest healthcare market in the GCC and tenth in the MENA region. Comprehensive Conference Agenda Ms Hayat Bayan, Commercial & Operations Director at IFP Qatar, outlined the dynamic structure of the three-day event, which features over 55 speakers, 25 presentations, five dialogue sessions, and four workshops. “Qatar Medicare includes daily one-on-one meetings between exhibitors and major hospitals, panel discussions, workshops, and an Open Stage segment that allows professionals to share their expertise. The event will conclude with the Qatar Medicare 2025 Healthcare Excellence Awards, recognising 15 categories of outstanding healthcare institutions and professionals,” Bayan said. She highlighted that the conference addresses key themes, including: Industry Voices and Strategic Partnerships Mr Nasser Mohammed Al Hajri, Chairman of Al Jazira Medical Group and Platinum Sponsor of the event, emphasised the importance of innovation and collaboration: “We will showcase our latest healthcare technologies and services while strengthening partnerships with the public sector. Our strategy focuses on expanding in the local market to meet Qatar’s growing healthcare demands.” Dr Zainab Al Moosa, CEO of Almoosa Specialist Hospital, noted the group’s participation as part of its regional growth strategy: “As a leading healthcare provider in Saudi Arabia, we aim to explore new opportunities for joint collaboration and expansion across the region through our participation in Qatar Medicare.” Dr Hadi Mohamad Abu Rasheed, Scientific Advisor at the Qatar Cancer Society (QCS), stressed the organisation’s commitment to raising public awareness and advancing cancer prevention: “As a Silver Sponsor, QCS is reinforcing its awareness role, focusing on cancer prevention, early detection, and public education. The event also allows us to explore partnerships that enhance healthcare innovation and improve the quality of life for patients.” Driving Innovation and Healthcare Excellence Qatar Medicare 2025 serves as a dynamic platform to connect innovators, policymakers, and investors, creating new opportunities for knowledge exchange and growth within the healthcare sector. Through its robust agenda, international participation, and collaboration between government and private stakeholders, the event underscores Qatar’s growing role as a regional hub for healthcare innovation and investment. Organised by: IFP QatarIn Collaboration with: Qatar ChamberVenue: Doha Exhibition & Convention Center (DECC)Dates: November 11–13, 2025
Qatar Medicare 2025 to Kick Off on November 11 at DECC
100 Local and International Companies to Participate in Qatar’s Leading Healthcare Exhibition The Qatar Chamber has announced the second edition of Qatar Medicare, the country’s premier international healthcare and medical exhibition and conference, taking place from 11–13 November 2025 at the Doha Exhibition and Convention Center (DECC). Organised by the Qatar Chamber in collaboration with IFP Qatar, and held under the patronage of the Ministry of Public Health, Qatar Medicare 2025 will bring together 100 exhibitors — including 64 local and 36 international companies from 14 countries — representing health professionals, hospitals, medical service providers, technology experts, and investors. Driving Innovation and Global Collaboration in Healthcare In his remarks, Ali Saeed Bu Sharbak Al Mansouri, Acting General Manager of Qatar Chamber, stated: “Qatar is witnessing remarkable progress in its healthcare sector, becoming one of the leading destinations for medical tourism in the Middle East. Qatar Medicare serves as a key platform to forge partnerships, attract investment, and enhance the sector’s global competitiveness — in line with the Third National Development Strategy and Qatar National Vision 2030.” Qatar: A Global Hub for Healthcare Innovation H.E. Sheikh Dr Mohammed bin Hamad Al Thani, Director of the Department of NCDs Prevention Programs at the Ministry of Public Health, emphasised Qatar’s rise as a global hub for healthcare innovation, noting that the Third National Health Strategy (2024–2030) focuses on quality, sustainability, and clinical excellence. According to Fitch Solutions, Qatar’s healthcare expenditure is projected to grow at a 14% compound annual rate by 2029, reaching USD 11.5 billion, making Qatar the third-largest healthcare market in the GCC and tenth in MENA. Expanding Participation and International Recognition Hayat Bayan, Commercial & Operations Director at IFP Qatar, said: “Qatar Medicare 2025 highlights the latest healthcare innovations and connects professionals, companies, and institutions worldwide. This year’s edition features strong international participation from 14 countries and institutions, including WHO, UNESCO, Africa CDC, and the International Labour Organisation.” The event features 40 expert speakers, 25 presentations, five panel sessions, and four workshops, concluding with the Qatar Medicare 2025 Healthcare Excellence Awards, which honour top-performing institutions and professionals. Industry Leaders at the Forefront A Global Platform for Healthcare Excellence Qatar Medicare 2025 underscores Qatar’s leadership in medical innovation, digital transformation, and public-private partnerships. Ranked first in the Arab world and 21st globally in the 2025 Healthcare Index, Qatar continues to build a world-class healthcare ecosystem, recognised by the WHO as the first nation where all municipalities are certified as Healthy Cities. Event Dates: 11–13 November 2025Venue: Doha Exhibition and Convention Center (DECC), Qatar
A National Milestone in Pediatric Care
Her Highness Sheikha Moza bint Nasser Inaugurates Pediatric Stem Cell Transplant Ward at Sidra Medicine Sidra Medicine, a member of Qatar Foundation, proudly announces the official inauguration of its state-of-the-art Pediatric Hematopoietic Stem Cell Transplant (HSCT) Ward, launched under the patronage of Her Highness Sheikha Moza bint Nasser. This marks a groundbreaking advancement in Qatar’s pediatric healthcare landscape — the country’s first dedicated ward offering bone marrow transplant services to children with complex blood disorders, genetic diseases, and immune system conditions. The new HSCT Ward is designed exclusively for patients under 18 years of age, delivering highly specialised care for conditions such as: Treatments include autologous (self-donated) and allogeneic (donor-based) hematopoietic stem cell transplants, also known as bone marrow transplants. Precision Medicine Meets Global Standards Sidra Medicine’s HSCT program is a cornerstone of its precision medicine strategy. The new ward features: This launch supports Qatar’s healthcare goals under Qatar National Vision 2030, including: As of mid-2025, the HSCT ward will begin autologous transplants, with preparations underway for allogeneic procedures. Future phases will include CAR-T cell therapies and Casgevy gene therapy for thalassemia and sickle cell disease. Dr. Iyabo Tinubu-Karch, CEO of Sidra Medicine: “The HSCT program strengthens our commitment to providing world-class, family-centered care—right here in Qatar.” Prof. Ibrahim Janahi, Chief Medical Officer: “This initiative is a major step toward building a knowledge-based, innovation-driven health system in line with Qatar’s national goals.” The HSCT Program at Sidra Medicine is open to both Qatari and international patients. More than 50 children are currently awaiting transplantation, and new patient referrals are now being accepted. To learn more about our Pediatric Hematology, Oncology, and HSCT services, or to refer a patient, please visit:🔗 www.sidra.org
“Our goal is to transform Qatar into a regional hub for healthcare”
In conversation with Manu G Parmar, Dr Saed Kaldari, CEO & founder of Surgi Art Hospital discusses a wide range of topics related to why he blended art in the name of the hospital, the goal of the facility and where he envisions it in two years’ time. BL: Talk us through your career path? Kaldari: I started my career as a physician. I graduated from the Royal College of Surgeons in Ireland in 1997. After that, I briefly returned home, only to leave again for Sweden to pursue a career in plastic surgery. I practised that for a while and eventually decided to come home in 2006. Before returning, I worked in Sweden at one of the university hospitals, where I held a locum consultant position, which I took on as I saw it would enhance my career. I worked for Hamad Medical Corporation at the start of my career for about 17 years. In 2014, I realised that I needed to focus on one thing, as I was managing both a private facility – a solo clinic from 2010 to 2013, and in 2013, I decided that this was not the way forward. I established a plastic surgery and dermatology centre in the Duhail area in 2014. With progress in this venture, I approached one of my friends in the business, the late Ibrahim Al Asmakh who was involved in real estate. Eventually with Al Asmakh and his partner, late Sheikh Khalid bin Nasser we expanded upon their hospitality, real estate (both commercial and residential), retail to add a healthcare unit, which I was assured, I would have complete control to execute it as I saw fit. In 2017, we signed the contract, marking the project’s official commencement and with efficient planning and budgeting, we offer our rooms at the same price as regular market rooms but with far superior services. It’s not about volume; we aim to introduce new, niche services. Our entire business model centres on providing specialised services and given the small market, investing in high-end technology and personnel locally is also challenging. Therefore, we promote our services to reach a wider geography, aligning with Qatar’s health tourism initiative. This initiative is gaining momentum, and we feel fortunate to be ready as it unfolds. The government is supporting the private sector in fostering growth, and we are proud to be part of this and help establish quality hospitals in Qatar. We can also attract specialised high-end practitioners worldwide, permanently or visiting. Our goal is to transform Qatar into a regional hub for healthcare, understanding and catering to our customers’ needs uniquely. We are optimistic about this continued success. BL: What made you think about this unique art and health care unison? Kaldari: Coming from a background in plastic surgery, you know you can’t help but think about the artistic application of medical science. It’s not just about plastic surgery; I realise that an orthopaedic surgeon, who cuts away at the correct angles, is an artist of sorts. I believe those who perform other types of surgery also have their own crafts. It’s a mix of knowledge and skill, both essential for success. There is artistry in it. I think this is where the name derives from: the artistry in providing care. The main idea is that when you walk in, you’ll notice one thing that’s different about this building. I was involved from an architectural perspective, including the layout and all the blueprints from day one. I faced a huge challenge trying to convince architects and engineers who were pushing for standard building concepts that this was not the direction I wanted to take. This is about the feel, more than anything else. You will notice when you walk around the hospital that there is a unique flow to the space. This flow is noticeable to anyone who passes by our facility; they feel an airy quality here, something flowing. There are many studies worldwide showing that you eat better in a pleasant environment, which I think is an important part of the services we provide. BL: Doha has quite a few upscale, modern hospitals. What do you think you will offer that will set the hospital apart? Kaldari: We have a medical background and have developed organically, not from a business perspective. Our goal is to expand into the health sector, a commitment my partners and I agreed upon from the start. This sector is unique because it requires a blend of skills. Running such a venture demands not just medical management but also sound business acumen to ensure feasibility. Merging these competencies is challenging, as it ultimately provides a different type of service. BL: What are the 5 USPs of this hospital? Kaldari: We have recently launched a uniquely designed medical facility in Qatar. The hospital features distinct architectural themes, creating a unique flow throughout the building as patients experience its services. We stand out by implementing the concept of a boutique hospital. While we function primarily as a surgical facility with ancillary medical services, we also provide general medical care with a strong emphasis on surgery. Our foremost department will be plastic surgery, alongside general surgery. Soon, we will include orthopaedic surgery, ENT, dermatology, obstetrics and gynaecology, and more specialities to come. Our state-of-the-art diagnostic facilities include laboratories and radiological testing. We have established collaborations with experts from North America, Europe, and even Asia to bring their services to Qatar, benefiting not only our local population but the entire region as well. BL: Medical insurance is a crucial success factor for a hospital’s success. What kind of insurance tie-ups have you done for the hospital? Kaldari: We have connected with all major insurance providers in Qatar and are now in the negotiation stage. As you know, the medical insurance sector in Qatar still has a long way to go in terms of development. It’s not operating optimally, and I believe it requires more governance. A regulatory authority is necessary to manage
Sidra Medicine Pioneers Genome Assembly Breakthrough for Rare Disease Research in the Middle East
5 April 2025, Doha, Qatar – In a groundbreaking advance for precision medicine and rare disease diagnosis, researchers at Sidra Medicine, a member of Qatar Foundation, have led a landmark genetic study that significantly enhances the representation of Middle Eastern populations in genomic research. Published in the prestigious journal Nature Genetics, the study titled “Near-complete Middle Eastern genomes refine autozygosity and enhance disease-causing and population-specific variant discovery” presents the first near-complete genome assemblies from the region. Leveraging long-read sequencing and de novo genome assembly, the research reveals new pathways to understand and resolve complex, undiagnosed neurodevelopmental disorders affecting families in Qatar, Sudan, Jordan, Syria, and Afghanistan. A New Era for Middle Eastern Genomics and Rare Disease Diagnosis The study provides a critical reference resource for the Middle East, filling major gaps in global genomic databases and offering a transformative tool for identifying disease-causing genetic variants. By constructing full genome sequences from scratch, the Sidra Medicine team achieved unprecedented accuracy, setting a new benchmark for population-specific genomic mapping. “We used long-read sequencing to gain deep insights into the genomes of Middle Eastern families affected by rare diseases,” said Prof. Younes Mokrab, Head of Medical and Population Genomics at Sidra Medicine. “This approach uncovers pathogenic variants that have remained elusive for years. It’s a game-changer for genomic medicine in the region.” Key Highlights of the Study: Prof. Evan Eichler, renowned genome scientist and co-author from the University of Washington, emphasiSed:“This work is essential for uncovering the full spectrum of genetic variation behind disease. It represents the future of clinical genomics, offering hope to families with previously unsolved conditions.” Driving Innovation in Precision Medicine and Global Health Equity Despite major strides in global genomics, Middle Eastern populations remain underrepresented in current genome references. Sidra Medicine’s research addresses this inequity by delivering a tailored genome dataset to improve diagnosis, treatment, and understanding of genetic diversity. “Our latest findings show that long-read technologies are essential for the next era of genetic discovery,” said Prof. Khalid A. Fakhro, Chief Research Officer at Sidra Medicine. “We’re now able to identify mutations missed by standard sequencing, paving the way for better outcomes in clinical care.” The implications go beyond medicine. The genetic insights from this study will also contribute to anthropological and population migration research, enhancing global understanding of Middle Eastern genomic evolution. Collaborative Impact and Future Directions Dr. Hamdi Mbarak, Director of Research at Qatar Precision Health Institute, remarked:“With over 25,000 Qatari genomes currently being analySed, the timing of this high-resolution reference for Middle Eastern genetics couldn’t be more critical.” Looking ahead, Prof. Mokrab emphasised the importance of expanding this initiative: “Our goal is to create a comprehensive Middle Eastern pangenome, integrating regional data into global initiatives. Together with our international partners, we aim to make these breakthroughs accessible and impactful for all.” Supported by Qatar’s Leading Research Institutions This study was made possible through the support of: To explore more about Sidra Medicine’s research on genomic science, visit www.sidra.org/research.Read the full study here: Nature Genetics Article
Opening of the Surgi Arts Hospital in Qatar
In a significant step that reflects Qatar’s commitment to developing the healthcare sector, His Excellency Dr. Mansour bin Ibrahim Al Mahmoud, Minister of Public Health, inaugurated the Surgi Arts Hospital on the 7th of April 2025. The hospital is considered one of the most advanced and luxurious medical facilities in the region. Located in the modern city of Lusail, in the vibrant heart of Doha, it is one of the most developed areas in Qatar. The hospital stands out for its innovative and unique architectural design, which was specifically crafted to align with the highest standards of healthcare quality and patient safety. This medical landmark spans an area of 30,000 square meters and includes state-of-the-art medical and surgical departments, extensive facilities like spacious and comfortable waiting areas, integrated cafeterias, gardens, and 225 parking spaces. The hospital houses 49 beds distributed across its specialized departments, 26 outpatient clinics, 5 dental clinics equipped with the latest medical technology. Additionally, the hospital includes 6 treatment rooms and 5 operating rooms designed to meet all surgical needs. In the field of cosmetic surgery, the hospital holds a prominent position due to owning one of the largest specialized departments in the private sector in Qatar. It also collaborates with international surgeons to provide advanced surgical solutions for its patients. The hospital offers specialized medical services across a wide range of disciplines, including pediatrics, gynecology and obstetrics, internal medicine, cardiology, vascular surgery, orthopedics, and general surgery. It also includes an advanced radiology department with MRI machines, CT scans, ultrasound, panoramic X-rays, and dental imaging. Moreover, there are advanced laboratories and pharmacies equipped with the necessary medications under the supervision of a specialized team. Surgi Arts Hospital aims to be the leading destination for medical tourism in the region by offering integrated, high-quality medical services that meet international standards, ensuring an elegant environment and patient privacy for individuals from around the world. The hospital is led by Dr. Saeed Mohammed Kaldari, CEO and founding partner, who oversees the provision of innovative healthcare that aligns with the State’s vision to promote medical tourism and support Qatar National Vision 2030.